Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
March 2019
in “
JAMA Dermatology
”
Studysummary This study found that persistent chemotherapy-induced alopecia is often more severe and diffuse than alopecia from endocrine therapy, with both conditions negatively impacting patients' emotional wellbeing, and moderate to significant improvement was observed with dermatologic therapy.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jamanetwork.com →